Georges Francois Leclerc Cancer Centre (CGFL) from Dijon France is one of the Unicancer Network French Comprehensive Cancer Centres opened in January 1967.
Referral center for breast cancer, gastrointestinal cancers, and rare tumors treatment is accredited as Clinical Research Centre (CRC) by the French National Cancer Institute (INCa) French since 2012 and has an Early-Stage Clinical Trials Unit (UPP) created in 2001, accredited as Early-Stage Clinical Trials and Innovative Treatment Centre (CLIP) since 2010.
Part of the Dijon Faculty of Medicine and the University of Burgundy France, CGFL Dijon is dedicated to university and post-graduate teaching of doctors and specialists in cancerology.
The Cancer Biology Transfer Platform of the center provides cutting-edge technological skills and multidisciplinary expertise: molecular Biology, immune-monitoring, histology and bioinformatics/biostatistics and the main area of research is the mechanisms of cancer immune response. It is coordinated by Research Unit UMR1231, Center for Translational and Molecular Medicine.
